Monthly Archives: March 2016

WeightNot Releases New Mobile App

Tool Enables Program Tracking from iOS and Android Devices

WeightNot Releases New Mobile App

Bethesda, MD, United States – March 31, 2016 /MarketersMedia/

Bethesda, MD: WeightNot, a company providing therapeutic nutrition and holistic weight loss plans that deliver rapid and sustainable results, has introduced a new mobile App. The new App allows WeightNot members to log and review their daily progress on the go from iOS and Android smartphones.

“Apps just make things easier – and diet and fitness tracking is no different,” commented WeightNot CEO Paul Amoruso. “The new WeightNot App gives our members a seamless and convenient way to document their journey to a healthier lifestyle, while also reinforcing the healthy habits that they are building along the way.”

The WeightNot App enables quick entry of body weight, body measurements, steps, water consumption, food selections, supplementation, sleep time and more. Members can also upload progress pictures and photos of every meal. All of the information that is tracked in the WeightNot App is automatically synchronized with the WeightNot Web Dashboard, so that data is available to members on the desktop too.

To make fitness tracking more convenient, the new WeightNot App also syncs with the popular FitBit™ bands, so that members who use these devices may have their fitness data automatically consolidated with meal and other program tracking information in the WeightNot App and dashboard.

About WeightNot: WeightNot is a weight loss company based in Bethesda, MD, and was founded in 2010. Since its commencement, WeightNot has served thousands of members with a satisfaction rate of over 90%. WeightNot helps members make healthy lifestyle changes that lead to rapid and sustainable weight loss.

For more information about us, please visit http://www.weightnot.com

Contact Info:
Name: Paul Amoruso
Email: press@weightnot.com
Organization: WeightNot
Address: 7801 Norfolk Avenue
Phone: 240-366-5050

Source: http://marketersmedia.com/weightnot-releases-new-mobile-app/108911

Release ID: 108911

Dawson James Securities Announces Closing of $1.75 Million Offerings with InspireMD, Inc.

BOCA RATON, FL / ACCESWIRE / March 31, 2016 / Dawson James Securities, Inc. in conjunction with InSpireMD Corporation (NYSE MKT: NSPR), announced today the closing of two separate equity offerings, with InspireMD receiving total gross proceeds of approximately $1.75 million before underwriting and other offering expenses. The Company intends to use the net proceeds from the Private Placement to conduct sales activities related to CGuard™ EPS™, and MGuard Prime™ EPS, and for general corporate purposes.

The two offerings were comprised of an underwritten public offering of 1,900,000 shares of common stock and warrants to purchase up to 950,000 shares of common stock (the Public Offering), and a separate private placement to certain of the Company’s officers and directors of up to 1,100,000 shares of its common stock and warrants to purchase up to 550,000 shares of common stock (the “Private Placement”). The common stock was priced at $0.59 per share, and the warrants for both offerings are immediately exercisable, expire in five-years and have an exercise price of $0.59 per share. Dawson James Securities Inc., acted as the sole book runner for the Public Offering, and was the Placement Agent for the Private Offering.

“InspireMD has made significant progress over the past year exemplified by its commercial launch in the European Union of its new CGuard™ product,” said Robert D. Keyser, Jr., Dawson James’ CEO. “We are pleased to assist the Company with additional growth capital as they continue their successful transition into the carotid and neurovascular interventional markets. Mr. Keyser continued, “Our strategy to utilize an effective combination of institutional investment funds along with broker-led retail investors continues to be an effective means of access to growth capital for companies like InspireMD.”

A shelf registration statement on Form S-3 declared effective by the Securities and Exchange Commission (“SEC”) on November 27, 2013, a prospectus supplement and accompanying prospectus related to the offering have been filed with the SEC and are available on the SEC’s website located at http://www.sec.gov. A copy of the final prospectus relating to the offering may be obtained by contacting Dawson James Securities, Inc., Attention: Prospectus Department, 1 N. Federal Highway, Suite 500, Boca Raton, FL 33432, Telephone: 561-391-5555.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About INSPIREMD

InspireMD seeks to utilize its proprietary MGuard™ with MicroNet™ technology to make its products the industry standard for embolic protection and to provide a superior solution to the key clinical issues of current stenting in patients with a high risk of distal embolization, no reflow and major adverse cardiac events.

InspireMD intends to pursue applications of this MicroNet technology in coronary, carotid (CGuard™), neurovascular, and peripheral artery procedures.

About Dawson James Securities

Dawson James Securities specializes in capital raising for small and microcap public and private growth companies primarily in the Life Science/Health Care, Technology and Consumer sectors and is a full service investment banking firm with research, institutional and retail sales, and execution trading and corporate services. Headquartered in Boca Raton, FL, Dawson James is privately held with offices in New York, California, Maryland and New Jersey. www.dawsonjames.com

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A Of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipates” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

Member FINRA/SIPC. For more information, please contact:

Elise Stern, Managing Director, Corporate Finance
estern@dawsonjames.com
561-208-2926

SOURCE: Dawson James Securities, Inc.

ReleaseID: 438320

How are These Healthcare Stocks Performing? – MYL, ZTS, HZNP, and AGN

NEW YORK, NY / ACCESSWIRE / March 31, 2016 / Lower costs and increased commercialization of generic drugs have made it easy for generic firms to compete with developers of branded medicines in past years. A strong performance is even expected for the segment through 2020, which makes stocks in this space an interesting study. Ahead of today’s trading session, ValuableInvestment.com has lined up the following four Healthcare stocks for your close examination: Mylan N.V. (NASDAQ: MYL), Zoetis Inc. (NYSE: ZTS), Horizon Pharma PLC (NASDAQ: HZNP), and Allergan PLC (NYSE: AGN). Know more about these stocks by clicking the link below:

http://valuableinvestment.com/tradealerts

Mylan N.V.’s stock saw a slight correction of 1.30% and finished Wednesday’s session at $46.40. A total volume of 2.21 million shares was traded. In the last one month, the stock has advanced 2.95%. The Company’s shares are trading below their 50-day moving average by 2.96%. Moreover, shares of Mylan traded at a PE ratio of 27.95 and have a Relative Strength Index (RSI) of 48.14. Sign up and get the alert on MYL at:

http://valuableinvestment.com/MYL

On Wednesday, shares in Zoetis Inc. recorded a trading volume of 5.31 million shares, higher than their three months average volume of 4.56 million shares. The stock ended the session 2.09% higher at $44.02. The Company’s shares have gained 7.21% in the last one month. The stock is trading 5.43% above its 50-day moving average. Furthermore, shares of Zoetis have an RSI of 62.10. The complimentary alert on ZTS can be activated at:

http://valuableinvestment.com/ZTS

Shares in Horizon Pharma PLC closed the day 0.95% higher at $16.01. A total volume of 2.34 million shares was traded. The stock is trading 6.85% below its 50-day moving average. The Company’s shares have an RSI of 47.38. Register for free on ValuableInvestment.com and access the latest strategies on HZNP at:

http://valuableinvestment.com/HZNP

At the closing bell yesterday, shares in Allergan PLC ended 0.52% higher at $274.94. A total volume of 3.21 million shares was traded, which was above their three months average volume of 2.86 million shares. The stock is trading below its 50-day moving average by 3.29%. Furthermore, shares of Allergan have an RSI of 43.56. The complete trade setup on AGN is available for free at:

http://valuableinvestment.com/AGN

About ValuableInvestment.com:

Valuable Investment was founded in 2006 and has been successfully alerting investors and shareholders of the most profitable ways to earn a living on Wall Street. A decade is a very long time so we must be doing something right. We encourage everyone to come and try our strategy and see how we have been changing the foundation of research for years.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third party research service company (the “Reviewer”). The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer and the Sponsor have not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author, the Reviewer, or the Sponsor (collectively referred to as the “Production Team”) in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein.

NO WARRANTY

ValuableInvestment.com, the Author, the Reviewer, and the Sponsor (collectively referred to as the “Publishers”) are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither valuableinvestment.com nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To read our disclosures, or for more information, visit http://valuableinvestment.com/

RESTRICTIONS

ValuableInvestment.com is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia.

CONTACT

For any questions, inquiries, or comments reach out to us directly at:

E-mail: press@valuableinvestment.com

SOURCE: ValuableInvestment.com

ReleaseID: 438319

CardioComm Solutions Announces 2016 Financing Update

TORONTO, ON / ACCESSWIRE / March 31, 2016 / CardioComm Solutions, Inc. (TSXV: EKG) (“CardioComm Solutions” or the “Company”), a global medical provider of consumer heart monitoring and medical electrocardiogram (“ECG”) software solutions, today announced that it has entered into an amendment to its current loan agreement with MD Primer Inc. (“MDP”) which extends the repayment date of the line of credit (“LOC”) provided to the Company until December 31, 2016.

The Company plans to retire or replace the current LOC and generate further funding through capital raised from expanded revenue sources and institutional investment opportunities. The Company further confirms the LOC, which has been in place since January 1, 2013, has not been drawn upon since April 2015. With HeartCheck™ ECG PEN devices confirmed to be carried for a second year on the shelves of Canadian retail pharmacies and with Windows-based GEMS™ arrhythmia software sales growing, the Company will specifically look to 2016 as the year for confirming expanded sales and marketing traction in the USA, internationally and for the introduction of new Smartphone connected and wearable devices under the HeartCheck™ ECG brand. Already in 2016 the Company has announced:

– a co-marketing agreement with China-based Bejing Choice Electronics, a subsidiary of Tianjin Chase Sun Pharmaceutical Co., Ltd,
– a US-based initiave to sell into pharmacies, physician offices and long-term care facilities, and
– a multi-year, India-based ECG services licensing and HeartCheck™ device sales agreement.

MDP is the only secured creditor of the Company and is under the control of Dr. Anatoly Langer who is CardioComm Solutions’ Chairman of the Board of Directors and the largest shareholder of the Company with ownership of 47 million common shares. The Company confirms Dr. Langer abstained from voting on the amendment when it received Board approval. The amendment remains subject to approval by the TSX Venture Exchange.

To learn more about the CardioComm Solutions’ GEMS™ and HeartCheck™ ECG products please see the Company’s websites at www.cardiocommsolutions.com and www.theheartcheck.com or contact the Company at sales@cardiocommsolutions.com.

About CardioComm Solutions

CardioComm Solutions’ patented and proprietary technology is used in products for recording, viewing, analyzing and storing electrocardiograms (ECGs) for diagnosis and management of cardiac patients. Products are sold worldwide through a combination of an external distribution network and a North American-based sales team. The Company has earned the ISO 13485 certification, is HPB approved, HIPAA compliant, and has received FDA market clearance for its software devices. CardioComm Solutions is headquartered in Toronto, Ontario, Canada.

FOR FURTHER INFORMATION PLEASE CONTACT:
Etienne Grima, Chief Executive Officer
1-877-977-9425 x 227
investorrelations@cardiocommsolutions.com
www.cardiocommsolutions.com

Forward-looking statements

This release may contain certain forward-looking statements and forward looking information with respect to the financial condition, results of operations and business of CardioComm Solutions and certain of the plans and objectives of CardioComm Solutions with respect to these items. Such statements and information reflect management’s current beliefs and are based on information currently available to management. By their nature, forward-looking statements and forward-looking information involve risk and uncertainty because they relate to events and depend on circumstances that will occur in the future and there are many factors that could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements and forward-looking information.

In evaluating these statements, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company does not assume any obligation to update the forward-looking statements and forward-looking information contained in this release other than as required by applicable laws, including without limitation, Section 5.8(2) of National Instrument 51-102 (Continuous Disclosure Obligations).

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: CardioComm Solutions, Inc.

ReleaseID: 438323

Teras Provides Technical Studies Update

CALGARY, AB / ACCESSWIRE / March 31, 2016 / Teras Resources Inc. (TSXV: TRA) (“Teras” or the “Company”): Teras is pleased to announce that the Company has made significant progress regarding its ongoing technical studies at its Cahuilla project located in Imperial County, California. The Cahuilla Project is a large epithermal, paleo-hot springs system hosting multiple bonanza-grade veins within an extensive body of disseminated gold/silver mineralization. For further information on the Cahuilla project refer to the NI 43-101 technical report entitled “Cahuilla Property 43-101 Technical Report,” filed on Sedar.

The primary objective of the technical studies program is to develop an improved and more comprehensive geologic model that will be used to more accurately locate diamond drill holes focused on targeting newly recognized high grade precious metal zones to increase the grade and tonnage of high grade mineralization. Teras has been working with Mine Development Associates of Reno, Nevada to create the new geologic model which now includes the following information:

– Kennecott detailed surface geology maps
– Kennecott magnetic and CSAMT geophysical data
– Historic reverse circulation and diamond drill hole geologic logs and assays generated by Newmont,
– Homestake, Torres Martinez Tribe and Kennecott
– Teras’ more recent reverse circulation and diamond drill hole geologic logs and assays
– Teras gravity, MT and IP geophysical data
– Teras surface geochemical sample locations and assay data
– Teras detailed cross sectional geologic interpretation

Teras has the capability to plan future drill holes, using a variety of three dimensional geologic features to more precisely target new and existing structures and/or veins that host higher grade gold and silver. For example, the following map was issued in a previous press release illustrating potential precious metal targets interpreted from the original, less comprehensive geologic model data:

Cahuilla Project – Gravity Geophysical Targets

To view an enhanced version of this image, please visit:
https://www.accesswire.com/uploads/19885_a1459373944462_85.jpg

In contrast, the illustration below is an example of a combination of model data that can now be used in the drill hole planning process illustrating significantly more detailed geology:

New High Grade Diamond Drill Targets

To view an enhanced version of this image, please visit:
https://www.accesswire.com/uploads/19885_a1459373944665_2.jpg

This 3D illustration includes surface topography with detailed geophysical resistivity data, structural geology, gold-silver resource boundary and many newly defined high priority drill target areas. For geologic planning of drilling, any aspect of the technical data in the model can be observed in any direction three dimensionally, for example from the surface, underground, in cross sections or any way desirable to pinpoint priority high grade targets for future diamond drill campaigns.

A substantial increase in the frequency of faulting has been observed with the new modeling, for example in the northern half of the geophysical resistor within the resource area in the eastern portion of the project. This area portrays a plumbing system in which gold-silver rich fluids were localized resulting in the formation of high grade veins. The new model data has revealed that south of this area, little faulting is seen on the surface because sinter covers the area masking intense structural deformation noted within a concentration of high grade veins that were intersected by past drilling.

Faulting is also concentrated in Central Canyon and the Modoc Shaft areas which represent two new high grade vein drill targets. These prospective target areas have never been drill tested although Teras’ surface geochemical sampling returned highly anomalous gold and silver values. Teras can now drill test both of these high priority targets since permits have been approved.

Mr. Toby Mancuso, Geologic and Mining Consultant to Teras who has been involved with Cahuilla since 1992 when Kennecott acquired the project, remarked “Our technical team is extremely satisfied with the progress of the technical studies program thus far and excited to begin applying the highly advanced geologic model for targeting diamond drill holes aimed specifically at high grade mineralization.”

“The greatly improved geologic model along with the recently approved drill permits for 2,000 additional holes has evolved Cahuilla to a new level of technical understanding. This new model provides our team a much higher level of confidence in planning future drill programs focused exclusively on increasing the high grade gold-silver resource.”

About Teras

Teras is focused on developing its Cahuilla project located in Imperial County, California. The project encompasses an area of at least 3 km by 1.5 km and Teras believes that the Cahuilla project has the potential to develop into a mining operation consisting of altered and mineralized sedimentary and volcanic host rocks with numerous sheeted high-grade quartz veins. Teras filed a NI 43-101 technical report with an indicated resource of 1.0 million ounces of gold and 11.9 million ounces of silver on its Cahuilla project (70 million tons at an average grade of 0.015 ounces per ton gold and 0.17 ounces per ton silver with a cut-off of 0.008 ounces per ton gold) and inferred class of 10 million tons grading 0.011 opt gold and 0.10 opt silver. Gold equivalent ounces are 1.2 million ounces in indicated class and 130,000 ounces in inferred class using a ratio of 55 silver ounces to 1 gold ounce.

Dale A Vitone P. Eng., registered with the Association of Professional Engineers of Ontario, Alberta and Northwest Territories and a director of Teras, is the Company’s nominated qualified person responsible for monitoring the supervision and quality control of the programs completed on the Company’s properties. Mr. Vitone has reviewed and verified the mining scientific and technical information contained in this news release.

For further project and corporate information, contact:

Teras Resources Inc.
Peter Leger, President
(403) 262-8411
(403) 852-0644
Email: pleger@teras.ca
Website: www.teras.ca

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy of accuracy of this news release.

This press release contains “forward-looking information” within the meaning of applicable Canadian securities legislation. All statements, other than statements of historical fact, included herein may be forward-looking information. Generally, forward-looking information may be identified by the use of forward-looking terminology such as “plans”, ” expects” or “does not expect”, “proposed”, “is expected”, “budgets”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. In particular, this press release contains forward-looking information regarding: the Cahuilla project, the development and advancement of the Cahuilla project, the development of the geologic model in respect of the Cahuilla project, the development of further drill plans in relation to the Cahuilla project and the potential of the Cahuilla project to develop into a mining operation; and the completed core drilling program including further analysis of the core drilling program, the evaluation of the core drilling program and its impact on the Company’s existing NI 43-101 technical report. This forward-looking information reflects the Company’s current beliefs and is based on information currently available to the Company and on assumptions the Company believes are reasonable. These assumptions include, but are not limited to, the actual results of exploration projects being equivalent to or better than estimated results in technical reports or prior exploration results, future costs and expenses being based on historical costs and expenses, adjusted for inflation, the ability of the Company to obtain acceptable financing, market acceptance of its exploration programs and projects; consistent and favorable commodity prices; and regulatory acceptance of the Company’s geologic models . Forward-looking information is subject to known and unknown risks, uncertainties and other factors that may cause the actual results, level of activity, performance or achievements of the Company to be materially different from those expressed or implied by such forward-looking information. Such risks and other factors may include, but are not limited to: the early stage development of the Company and its projects; general business, economic, competitive, political and social uncertainties; commodity prices; the actual results of current exploration and development or operational activities; competition; changes in project parameters as plans continue to be refined; accidents and other risks inherent in the mining industry; lack of insurance; delay or failure to receive board or regulatory approvals; changes in legislation, including environmental legislation, affecting the Company; timing and availability of external financing on acceptable terms; conclusions of economic evaluations; and lack of qualified, skilled labour or loss of key individuals. Although the Company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. Accordingly, readers should not place undue reliance on forward-looking information. The Company does not undertake to update any forward-looking information, except in accordance with applicable securities laws.

SOURCE: Teras Resources Inc. 

ReleaseID: 438322

Nevada Zinc Announces Closing of $2,000,000 Financing

TORONTO, ON / ACCESSWIRE / March 31, 2016 / Further to its news releases dated March 15, 16 and 23, 2016, Nevada Zinc Corporation (TSXV: NZN) (the “Company“) is pleased to announce the completion of its previously announced non-brokered private placement for gross proceeds of $2,000,000 (the “Offering”) through the sale of 6,666,665 common shares in the capital stock of the Company (the “Shares“) at a price of $0.30 per Share.

In connection with the Offering, a finder’s fee (the “Finders Fee”) was paid to certain eligible finders in an amount equal to 8% of the Offering. The Finder’s Fee was comprised of $19,116 in cash and 469,613 common shares of the Company, at a deemed value of $0.30 per common share. In addition, an aggregate of 533,333 non-transferrable share purchase warrants (“Finder’s Warrants“) were issued in an amount equal to 8% of the number of Shares placed by eligible finders pursuant to the Offering. Each Finder’s Warrant, which has an expiry date of March 31, 2018, entitles the holder to acquire one common share of the Company at an exercise price of $0.30 per common share.

All Shares are subject to a statutory four month and one day hold period expiring on August 1, 2016.

The net proceeds of the Offering will be used for exploration, metallurgical test work and general working capital purposes.

Norvista Capital Corporation (“Norvista“), an insider of the Company by virtue of its beneficial ownership of securities of the Company carrying more than 10% of the voting rights attached to all the Company’s outstanding voting securities, purchased 666,666 Shares pursuant to the Offering. Norvista Capital I Limited Partnership (“LP“), an institutional funding vehicle, of which a wholly-owned subsidiary of Norvista serves as the general partner of the LP, purchased 666,666 Shares pursuant to the Offering. Norvista now has beneficial ownership of, or control or direction over, an aggregate of 8,597,665 common shares of the Company or approximately 13% of the total common shares issued and outstanding. The participation of Norvista pursuant to the Offering constituted a “related party transaction” within the meaning of Multilateral Instrument 61-101 – Protection of Minority Security Holders in Special Transactions (“MI 61-101“) and the policies of the TSX-V. The Company is relying upon the exemptions from the formal valuation and minority shareholder approval requirements pursuant to sections 5.5(b) and 5.7(1)(a), respectively, of MI 61-101 on the basis that the Company is not listed on a specified stock exchange and, at the time the Offering was agreed to, neither the fair market value of the subject matter of, nor the fair market value of the consideration for, the transaction insofar as it involves interested parties (within the meaning of MI 61-101) in the Offering, exceeded 25% of the Company’s market capitalization calculated in accordance with MI 61-101. The Company was not in a position to file a material change report more than 21 days in advance of the closing of the Offering as the details of participation by Norvista was not known at such time.

About Nevada Zinc Corporation

The Company is a discovery driven, early-stage mineral exploration company with a proven management team focused on identifying unique opportunities in mineral exploration that can provide significant value to its shareholders. The Company’s existing projects are located in Nevada and Yukon.

For further information contact:

Nevada Zinc Corporation
141 Adelaide St. West, Suite 1660
Toronto, Ontario M5H 3L5
Tel: 416.504.8821
Bruce Durham, President and CEO
bdurham@nevadazinc.com

www.nevadazinc.com

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE: Nevada Zinc Corporation

ReleaseID: 438321

Quest Solution, Inc. Schedules Conference Call to Discuss Fourth Quarter and Year End 2015 Financial Results

Call Scheduled for April 13, 2016 at 4:30 p.m. ET

EUGENE, OR / ACCESSWIRE / March 31, 2016 / Quest Solution, Inc, (OTCQB: QUES), a specialty systems integrator focused on field and supply chain mobility, today announced that management will conduct a conference call on Wednesday, April 13, 2016 at 4:30 p.m. ET. Management will discuss the Company’s financial results for the fourth quarter and year end, provide a general corporate update and conduct a question and answer period.

Conference call information:

Date and time: Wednesday, April 13, 2016 at 4:30 p.m. ET
Dial-in number: 1-877-830-2629 (domestic) or 1-785-424-1231 (international)
Replay number: 1-877-481-4010 (domestic) or 1-919-882-2331 (international). Please use passcode 10017 to access the replay. The replay will be available until May 13, 2016.

Webcast link: http://www.investorcalendar.com/IC/CEPage.asp?ID=174888

Quest Solution, Inc. required additional time to complete the accounting and reporting for certain activities and disclosures, and could not finalize its Annual Report on Form 10-K in sufficient time to permit its filing within the prescribed time period without unreasonable expense and effort. The delay in processing is a result of the acquisition of ViascanQData on November 6, 2015. Quest Solution is working expeditiously to complete the Annual Report and expects that the Annual Report will be filed no later than the 15th calendar day following the prescribed due date.

About Quest Solution, Inc. www.questsolution.com

Quest Solution is a Specialty Systems Integrator focused on Field and Supply Chain Mobility. We are also a manufacturer and distributor of consumables (labels, tags, and ribbons), RFID solutions and barcoding printers. Founded in 1994, Quest is headquartered in Eugene, Oregon, with offices in the United States and Canada.

Rated in the Top 1% of global solution providers, Quest specializes in the design, deployment and management of enterprise mobility solutions including Automatic Identification (AIDC), Mobile Cloud Analytics, RFID (Radio Frequency Identification) and proprietary Mobility software. Our mobility products and services offering is designed to identify, track, trace, share and connect data to enterprise systems such as CRM or ERP solutions. Our customers are leading Fortune 500 companies from several sectors including manufacturing, retail, distribution, food / beverage, transportation and logistics, health care and chemicals / gas / oil.

Investor Contacts:

Hayden IR
Brett Maas
(646) 536-7331
brett@haydenir.com

Cameron Donahue
(651) 653-1854
cameron@haydenir.com

SOURCE: Quest Solution, Inc.

ReleaseID: 438312

Thermalabs to Go Ahead and Create another Batch of Its Back Applicator Deluxe

Cosmetics firm Thermalabs has said that they will go ahead with plans to produce another batch of the company’s back applicator deluxe.

Thermalabs to Go Ahead and Create another Batch of Its Back Applicator Deluxe

New York, United States – March 31, 2016 /MarketersMedia/

Thermalabs has Okayed plans to produce another batch of its back applicator deluxe. This is following initial test runs that proved the product’s potential in the market. For most of its releases, Thermalabs produces an initial inventory with the goal of gauging user interest in the product, and then decides whether to continue producing or not. The fact that the company is going ahead with this particular applicator is a sign that it’s got a lot of potential in the global cosmetics industry.

Thermalabs is an American company that’s based in New York. The firm has a number of production facilities in Israel and other parts of the world, where teams of researchers work on new, innovative formulations that are based on natural and organic ingredients. Indeed, Thermalabs is committed to a skin cancer-free world. The company works to flood the market with highly organic and natural tanning and general cosmetics aids that will discredit the need to rely on the sun for a tan. According to the American Cancer Society, millions of people get skin cancer after over-exposing their skin to the sun’s harmful rays, mostly while trying to achieve that sexy, attractive tan. In line with its goals and long-term commitments, Thermalabs also contributes a significant chunk of its annual profits to charity. The majority of beneficiaries are nonprofit organizations that are creating awareness on skin cancer, and educational teams that work to find a cure for cancer.

Thermalabs announced its back applicator deluxe some few weeks ago. The product was apparently designed to fill gaping holes in the market. It’s marketed as a premium choice for people who often find it hard to apply tanning lotion on their back and other unreachable parts of the body. Thermalabs back applicator deluxe ships with four extra replacement sponges, as well as a luxurious velvet pouch for easy storage and travel. The product is recommended with any of the company’s tanners, sun blocks and moisturizers. However, it’s also compatible with similar products from other brands. Thermalabs offers a full year guarantee on this particular product. Considered that the company will be producing more of these, it’s likely that they’ll intensify marketing efforts for this product, as well as make it available in other countries outside the US.

Melanie M., an Amazon user who used Thermalabs back applicator deluxe, reviewed, “My back tends to get itchy pretty much all year – in the winter from the dry weather, and in the summer from chlorine in the pool. I have a bit of arthritis in my shoulders which makes certain motions with my arms difficult, so I was always bothering my hubby to rub lotion on my back. I wasn’t sure if I could use this kind of an applicator but thought I’d give it a whirl. Boy was I pleasantly surprised! It’s extremely lightweight and has a good reach, even for someone with limited range. The lotion glides on my back and I have no problem covering all areas. No more bothering my hubby! It comes in a sturdy cardboard cylinder with 4 extra sponges – a nice plus. The sponges look to be of good quality and they’re easy to clean. The applicator folds in half and fits nicely in the accompanying velvet pouch for easy storage or for travel. Just be sure to snap it in place when extending it for use.”

For more information about us, please visit http://www.thermalabs.com

Contact Info:
Name: Jennifer Parker
Email: press@thermalabs.com
Organization: Thermalabs

Video URL: https://www.youtube.com/watch?v=AVamgm2obP0

Source: http://marketersmedia.com/thermalabs-to-go-ahead-and-create-another-batch-of-its-back-applicator-deluxe/108958

Release ID: 108958

Thermalabs Exfoliating Gloves Outperforming Expectations on Amazon

One of Thermalabs most recent products seems to be outperforming critics’ expectations on Amazon.com, the world’s leading e-commerce marketplace.

Thermalabs Exfoliating Gloves Outperforming Expectations on Amazon

London, United Kingdom – March 31, 2016 /MarketersMedia/

Thermalabs exfoliating gloves set appears to be doing extraordinarily well in the marketplace. Recently, the company announced that it had secured a patent for this premium product. This was great news for users, especially those who are keen to rely on verified, credible products to make their skin look more beautiful. Thermalabs released the exfoliating gloves set sometimes in February. Following a series of brilliant marketing stunts, as well as a strategic bring-to-market approach that involved highlighting the product’s unique benefits, it finally appears that the company has been able to break the glass ceiling.

The exfoliating gloves set is a pack of 3 premium bath exfoliators that are all natural and eco-friendly. These include a loofah and natural bamboo mitt, a natural sisal mitt and a jute mitt. Again, it’s evident that Thermalabs was keen to rely on exclusively natural ingredients. The company has marketed its exfoliating gloves set as the best set of natural exfoliating scrub mitts available in the market. The product ships with an in-depth exfoliating guide that provides essential tips so that users can exfoliate like pros. As if that’s not enough, Thermalabs has rolled out the industry’s only full year guarantee on an exfoliating gloves product.

The product is currently a hot new release on Amazon.com, the world’s premium online shopping marketplace. The company sells most (if not all) of its products on Amazon, and on its official website. Amazon’s ‘hot new release’ is a coveted list that highlights a top-quality product that is able to meet users’ expectations. Before a product can make it to this list, it has to attract substantive purchases, as well as record top ratings and positive reviews from users who’ve actually bought and used the product. For a product that’s less than 2 months old, making it to this list is considered an extraordinary achievement. Thermalabs exfoliating gloves set is not the first of the company’s product’s to feature in this list. The company’s ‘original self-tanner’, Glow2Go tanning wipes, Ultimitt tan applicator and a number of other products all made it to the ‘hot new release’ list before they turned out to be some of the firm’s all-time top-grossing products.

In addition to featuring as a hot new release, Thermalabs exfoliating gloves mitt has also garnered a five-star rating from over 120 users on Amazon.com. Dinokc, a customer who bought and used this product on amazon, reviewed, “These gloves are made of all natural fibers each are good for different skin issues and types. The gloves also came with an informational booklet which explained how to determine which glove is right for you and also a guide on the maintenance and care of your glove so they stay up to par. My favorite glove is the bamboo fiber glove it unclogs pores and exfoliates very well. Though it looks rough upon opening the bamboo fibers expand when water is present. The pack also comes with a bonus finger exfoliator for use in small areas such as your face it’s pretty handy for cleaning the pores around your nose. Overall I think this was a great system and the booklet was very informative.”

For more information about us, please visit http://www.thermalabs.com

Contact Info:
Name: James McCarthy
Organization: Thermalabs

Video URL: https://www.youtube.com/watch?v=vYHl45Cymuw

Source: http://marketersmedia.com/thermalabs-exfoliating-gloves-outperforming-expectations-on-amazon/108944

Release ID: 108944

BlueHorseshoeStocks.com to Present on Cannabis Investor Webcast

ROCHESTER, NY / ACCESSWIRE / March 31, 2016 / BlueHorseshoeStocks.com (BHS) is a blog-style website that offers a free daily stock alert newsletter to stock and options traders of all levels from beginning to advanced. Unlike your typical stock-picking service, BHS publishes a quality newsletter on a daily basis, giving its members a wide range of trading ideas including microcaps to big board stocks, options ideas and more.

For years, BHS has tracked and shared cannabis-related stock ideas with its readers, and enjoyed quite a bit of success in doing so. BHS is pleased to announce that it will present online on the CannaInvestor Webcast today Thursday, March 31, 2016 at 1:00 PM EDT – 1:45 PM EDT.

“We began profiling medical and legal cannabis stocks well before the sector caught the investment community by storm, back in 2012. We’ve continually tracked a multitude of plays within the space in the time since then, which have provided our subscribers with many chances to profit,” states BHS owner Peter Nicosia. “I’m very excited to appear on the CannaInvestor Webcast to relate some of my thoughts and experiences with the industry.”

Cannabis investors, analysts, executives, media, and consumers who would like to attend the free online webcast, please click on the link www.cannawebcast.com and visit the Registration Page. After you register you will receive a link via e-mail to access the webcast on presentation day. To view the recorded presentations please visit www.youtube.com and search for CannaInvestor Webcast two weeks after the live presentation.

Contact for Blue Horseshoe Stocks:

Peter Nicosia, Owner
585-703-6565
http://bluehorseshoestocks.com/

SOURCE: Blue Horseshoe Stocks

ReleaseID: 438318